← Leaderboards
Alan Cowan
Temple University
$2,466,996
Attributed
$2,466,996
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $371.9K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,466,996 · 2
By mechanism
P30$2,466,996 · 2
Top collaborators
No co-investigators on record.
Most similar at Temple University
Same institution · by research overlap
- Lee-Yuan Liu-Chen$14,991,699
- Thomas J Rogers$17,103,492
- Marvin C Ziskin$4,699,296
Others in their field
Top investigators on “Microdialysis”
- Leonard L Howell · Emory University$16,286,809
- Jerome M Siegel · University Of California Los Angeles$14,997,651
- William Joseph McBride · Indiana Univ-Purdue Univ At Indianapolis$12,891,522
- Klaus A Miczek · Tufts University Medford$12,529,122
- David M Holtzman · Washington University$11,460,215
- Sara R Jones · Wake Forest University Health Sciences$10,628,023
Research focus
MicrodialysisBrainDrug CombinationsPharmacologySiteBody TemperatureGastric EmptyingExperimental DesignsIntestinesPharmaceutical PreparationsPhysical DependenceServicesNeurologicRattusBehaviorData AnalysesDrug InteractionsDrug Of AbuseAnalgesicsRegulationAreaAntipruriticsAnti-Inflammatory AgentsCarrageenan
Grant awards (13)
Integrative Core$202,340
P30 · FY2014 · DA · contact PI
Integrative Core$194,406
P30 · FY2013 · DA · contact PI
Integrative Core$202,654
P30 · FY2012 · DA · contact PI
Integrative Core$202,778
P30 · FY2011 · DA · contact PI
Integrative Core$202,961
P30 · FY2010 · DA · contact PI
INTEGRATIVE PHARMACOLOGY CORE$371,860
P30 · FY2009 · DA · contact PI
INTEGRATIVE PHARMACOLOGY CORE$361,035
P30 · FY2008 · DA · contact PI
INTEGRATIVE PHARMACOLOGY CORE$294,311
P30 · FY2007 · DA · contact PI
INTEGRATIVE PHARMACOLOGY CORE$218,856
P30 · FY2006 · DA · contact PI
INTEGRATIVE PHARMACOLOGY CORE$215,795
P30 · FY2005 · DA
Core--Integrative pharmacology$0
P30 · FY2002 · DA
Core--Integrative pharmacology$0
P30 · FY2001 · DA
Core--Integrative pharmacology$0
P30 · FY2000 · DA